MAP's Migraine Drug Provides Big Pain Relief

A migraine drug from MAP Pharmaceuticals(MAPP Quote) provided significant relief from headache pain and other symptoms, according to results from a phase III study released Tuesday.

The Mountain View, Calif.-based drugmaker is developing the migraine drug, known as Levadex, on its own, although MAP is expected to seek out a larger drug company as a partner based on the positive results from this first of two planned phase III studies.

Levadex is an inhaled form of dihydroergotamine (DHE), a drug used intravenously to treat migraines. Migraine sufferers breathe Levadex into their lungs using MAP's proprietary inhaler. ...